Innovation, Investment, and Global Influence
by Chandra Rao, Commercial Pharma specialist & Senior Advisor to Ciesco.
Chandra Rao, Ciesco Senior Advisor specialising in healthcare strategy, shares his insights on China’s rapid emergence as a global biotechnology powerhouse.
Drawing on decades of international experience, Chandra explores how government policy, talent repatriation, and investment have reshaped the global biotech landscape.
He examines how China’s ambition to climb the life sciences value chain is influencing cross-border dealmaking, innovation, and global healthcare dynamics.
READ FULL ARTICLE “THE RISE OF CHINA IN BIOTECHNOLOGY” BY CHANDRA RAO
Chandra Rao, Senior Advisor, Pharma & Healthcare
China’s rise in biotechnology is a testament to how sustained investment, and a willingness to adapt and lead is important in this sector where timelines in bringing products to market is fraught with significant challenges. While there are significant geopolitical tensions that have emerged this has not halted the pace of dealmaking.
For any questions or comments, please contact Rebecca Gunner, Executive Assistant & Operations – rebecca.gunner@ciesco.com